Simulations Plus is expanding its partnership with NVIDIA by integrating the NVIDIA BioNeMo Agent Toolkit into Composer, its platform for model-informed drug development. Within this toolkit, AI agents use NVIDIA Nemotron Parse to scan scientific research papers, pull out relevant findings, and show exactly which paper each finding came from, so researchers can verify the source themselves instead of relying on the AI alone.
The partnership also includes nvQSP, a project that runs the complex simulations used to model drug behavior on NVIDIA GPUs, allowing researchers to test more scenarios in less time. Simulations Plus contributes its scientific modeling expertise and validated computational engines, ensuring the AI agents’ outputs stay grounded in proven drug development science rather than relying on AI reasoning alone.
Image generated by: ChatGPT